Research and analysis

Impact assessment opinion: Falsified Medicines Directive 2011/62/EU

Evaluation of the Department of Health impact assessment for Falsified Medicines Directive 2011/62/EU



View the impact assessment under evaluation

The Regulatory Policy Committee (RPC) gives independent advice to government on the quality of analysis supporting new regulations.

Following scrutiny of an impact assessment (IA) carried out prior to a regulatory proposal, the RPC provides an ‘opinion’ on the quality of analysis and evidence presented in the IA. This opinion then informs the decisions of ministers as to whether they proceed or not with the proposal.